Prevalence and Significance of Potential Pharmacokinetic Drug–Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials

被引：0
|
作者：
Sawsan Rashdan
Hui Yang
Tri Le
Christopher Selby
David E. Gerber
Carlos A. Alvarez
机构：
[1] University of Texas Southwestern Medical Center,Harold C. Simmons Comprehensive Cancer Center
[2] Texas Tech University Health Sciences Center,Pharmacy Practice
[3] University of Texas Southwestern,Internal Medicine
[4] University of Texas Southwestern,Population and Data Sciences
[5] Veterans Affairs North Texas HSC,Pharmacy and Research Services
来源：
Clinical Drug Investigation | 2021年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：161 / 167
页数：6
相关论文
共 50 条
  • [1] Prevalence and Significance of Potential Pharmacokinetic Drug-Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials
    Rashdan, Sawsan
    Yang, Hui
    Le, Tri
    Selby, Christopher
    Gerber, David E.
    Alvarez, Carlos A.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (02) : 161 - 167
  • [2] Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients
    Zhang, Jiali
    Ma, Danyi
    Chen, Meng
    Hu, Yanting
    Chen, Xveying
    Chen, Jingyu
    Huang, Man
    Dai, Haibin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [3] Prevalence and significance of drug-drug interactions among patients with lung cancer
    Rashdan, Sawsan
    Yang, Hui
    Le, Tri
    Hsieh, David
    Alvarez, Carlos A.
    Gerber, David
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy
    Mohammad Ismail
    Sehrash Khan
    Fahadullah Khan
    Sidra Noor
    Hira Sajid
    Shazia Yar
    Irum Rasheed
    BMC Cancer, 20
  • [5] Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy
    Ismail, Mohammad
    Khan, Sehrash
    Khan, Fahadullah
    Noor, Sidra
    Sajid, Hira
    Yar, Shazia
    Rasheed, Irum
    BMC CANCER, 2020, 20 (01)
  • [6] Potential statin-drug interactions: prevalence and clinical significance
    Zhelyazkova-Savova, Maria
    Gancheva, Silvia
    Sirakova, Vera
    SPRINGERPLUS, 2014, 3 : 1 - 8
  • [7] Prevalence of Potential Drug-Drug Interactions in Cancer Patients at Cancer Hospitals in Pakistan
    Pervaiz, Fahad
    Khan, Muhammad Z. U.
    Azhar, Saira
    Hussain, Arslan
    Masood, Junaid
    Zaib-Un-Nisa
    Khan, Muazzam A.
    Murtaza, Ghulam
    LATIN AMERICAN JOURNAL OF PHARMACY, 2014, 33 (07): : 1159 - 1166
  • [8] Prevalence and Clinical Significance of Drug-Drug and Drug-Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece
    Spanakis, Marios
    Melissourgaki, Maria
    Lazopoulos, George
    Patelarou, Athina E.
    Patelarou, Evridiki
    PHARMACEUTICS, 2021, 13 (02) : 1 - 20
  • [9] Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
    Lauren A. Marcath
    Taylor D. Coe
    Emily K. Hoylman
    Bruce G. Redman
    Daniel L. Hertz
    BMC Cancer, 18
  • [10] Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
    Marcath, Lauren A.
    Coe, Taylor D.
    Hoylman, Emily K.
    Redman, Bruce G.
    Hertz, Daniel L.
    BMC CANCER, 2018, 18
12345